|
Volumn 10, Issue 3, 2004, Pages 290-294
|
The World Federation of Hemophilia's third global forum on the safety and supply of hemophilia treatment products, 22-23 September 2003, Budapest, Hungary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9 CONCENTRATE;
BLOOD CLOTTING FACTOR CONCENTRATE;
BLOOD DERIVATIVE;
FRESH FROZEN PLASMA;
PROTHROMBIN COMPLEX;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT BLOOD CLOTTING FACTOR 9;
VON WILLEBRAND FACTOR;
BLOOD SAMPLING;
BLOOD TRANSFUSION;
CONFERENCE PAPER;
CREUTZFELDT JAKOB DISEASE;
CRYOPRECIPITATE;
DISEASE TRANSMISSION;
DRUG COST;
DRUG MARKETING;
DRUG QUALITY;
DRUG SAFETY;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE FINANCING;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH ECONOMICS;
HEMOPHILIA;
HEMOPHILIA A;
HEMOPHILIA B;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUNGARY;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
QUALITY CONTROL;
VON WILLEBRAND DISEASE;
|
EID: 2342653510
PISSN: 13518216
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2516.2004.00901.x Document Type: Conference Paper |
Times cited : (6)
|
References (0)
|